Presentation is loading. Please wait.

Presentation is loading. Please wait.

William Vega-Ocasio MD. Internal Medicine - Nephrology

Similar presentations


Presentation on theme: "William Vega-Ocasio MD. Internal Medicine - Nephrology"— Presentation transcript:

1 William Vega-Ocasio MD. Internal Medicine - Nephrology
Centro Renal Hospital Menonita Cayey Ext. 5503

2 The Dietitian Intervention
Diabetic Nephropathy The Dietitian Intervention

3 Objectives Definition of Diabetic Nephropathy
Prevention and management of Diabetic Nephropathy Nutritional Management of Diabetics with Advance Renal Disease

4 Overview Diabetes Mellitus
Disorder of impaired carbohydrates metabolism. Either Insulin deficiency or Insulin resistant state. Characterized by hyperglycemia (inadequate production or utilization of insulin). Multi systemic organ damage : eyes, nerves, blood vessels, heart and kidneys.

5

6 Overview Diabetes Mellitus
Advance glycosylation of tissue proteins (AGEP) Irreversible glycosylation of Hemoglobin Microvascular damage ( nephropathy & retinopathy) Renal and Cardiovascular complications Direct effect in Lipid metabolism

7 Diabetic Nephropathy Leading cause of and contributor to End Stage Renal Disease “ESRD” (CKD V) Development is related to duration of diabetes and degree of hyperglycemia Progresses in stages to CKD V if not treated

8 Diabetic Nephropathy Occurs in both DM Type I & II
Peak incidence of disease for Type I diabetics is between years after onset of disease Usually already present for those diagnosed with Type II Diabetes

9 Diabetic Nephropathy HEART VASCULAR SYSTEM KIDNEY

10 Diabetic Nephropathy Characterized : Microvacular damage to kidney
Earliest clinical evidence is appearance of microalbuminuria (incipient nephropathy) Slowly progressive disorder Untreated will result in massive protein excretion and decreased glomerular filtration rate (↓ GFR)

11 Untreated Diabetic Nephropathy

12 Diabetic Nephropathy Hyperglycemia Nephropathy ESRD

13 Diabetic Nephropathy STAGE GFR URINE PROTEIN BP
I. Hyperfiltration Super normal <30mg/day Normal II. Micro- Alb High-Normal mg/day Rising III. Proteinuria Normal-Decreasing <300mg/day Elevated IV. Nephropathy Decreasing Increasing Elevated V. ESRD <15mL/min Massive Elevated National Kidney Foundation “Primer on Kidney Diseases” Fourth edition Elsevier Saunders

14 From EdREN, the website of the Renal Unit of the Royal Infirmary of Edinburgh

15 Diabetic Nephropathy Stage I
Stage I-A Increased Kidney Filtration Osmotic load and Toxic effects of hyperglycemia Increased Glomerular Filtration Rate Kidney enlargement Stage I-B Silent Phase Hyperfiltration Hypertrophy Increased production of inflammatory mediators

16 Diabetic Nephropathy Stage II
Microalbuminuria (30-300mg/day) Basement membrane thickening due to AGEP’s Increased Microvascular damage Cardiovascular disease and retinopathy 20% risk of nephropathy within 5 years with standard care Glomerular Filtration Rate not markedly affected, but kidney inflammatory damage

17 Diabetic Nephropathy Stage III
Proteinuria (>300mg/day) Decreased Glomerular filtration Rate Severe protein wasting with it complications Up to 10% of patients may excrete < 3000mg/day Systemic microvascular and cardiovascular disease complications Abnormal lipid metabolism (Cholesterol & Triglycerides)

18 Diabetic Nephropathy Stage IV
Prepare for Treatment Progressive nephropathy Markedly decreased GFR Signs and Symptoms of Protein Calorie malnutrition Advance Retinopathy Cardiovascular catastrophes Cerebrovascular catastrophes

19 Diabetic Nephropathy Stage V
End Stage Renal Disease (CKD V) Renal Replacement therapy Severe protein calorie malnutrition Severe peripherovasclular disease Cerebrovascular Disease Cardiovascular Disease Infections

20 Objectives Definition of Diabetic Nephropathy
Prevention and management of Diabetic Nephropathy Nutritional Management of Diabetics with advance Renal Disease

21 Progression of Disease
Diabetic Nephropathy Hyperglycemia Nephropathy ESRD Progression of Disease Regression of Disease

22 National Kidney Foundation

23 Diabetic Nephropathy Stages of CKD I : Above normal GFR
II : Glomerular Damage, Microalbuminuria (30-300mg/day) III : Proteinuria (>300mg/day),Hypertension IV : More Glomerular Damage, Increasing Proteinuria, Decreased GFR → Azotemia V : GFR < 15ml/min/1.73m2 → Renal Replacement Therapy

24 From Chronic Kidney Disease, Dialysis, and Transplantation, Second Edition, Elsevier Saunders 2005

25 From Chronic Kidney Disease, Dialysis, and Transplantation, Second Edition, Elsevier Saunders 2005

26 Prevention or Regression of Disease

27 Prevention or Regression of Disease
Glycemic Control Hypertension Control Control Microalbuminuria or Proteinuria Dietary Protein Restriction* Treatment of Dyslipidemias

28 Diabetic Nephropathy Glycemic Control
Partially reverse glomerular hypertrophy and hyperfiltration Delay development of microalbuminuria Delay the onset or progression of nephropathy Delay onset of microvascular damage to organs

29 Up to Date ® Database ;ADA position Statement : Nephropathy in diabetes

30 Diabetic Nephropathy Hypertension Control
Single most effective measure for delaying progression of Chronic Kidney Disease Aggressive treatment is able to decrease the rate of Diabetic Nephropathy Progression Reduce microvascular cardiac, retinal and systemic complications Goal BP Target ≤ 130/85 in diabetics Goal BP Target ≤ 125/75 in nephropathy

31 Up to Date ® Database ;ADA position Statement : Nephropathy in diabetes

32 Diabetic Nephropathy Antihypertensive Agents
Angiotensin converting enzyme inhibitors (ACE) Angiotensin Receptor Blocker (ARB) Calcium Channel Blocker (CCB) Diuretics ( Loop and Thiazides ) β – Blockers α – Blockers

33 Diabetic Nephropathy Control Microalbuminuria or Proteinuria
Untreated will accelerate the progression of diabetic nephropathy ACE inhibitors delay progression of nephropathy in Type I DM ACE inhibitors and ARB’s delay progression from microalbuminuria to proteinuria In Type II DM ARB’s delay progression to nephropathy in Type II DM with HTN and CKD

34 Up to Date ® Database ;ADA position Statement : Nephropathy in diabetes

35 Diabetic Nephropathy Dietary Protein Restriction Careful Restriction
Not all patients are candidates Helps by reducing hyperfiltration Helps by reducing intraglomerular pressure Retards progression of renal disease Recommendations grams per kilogram of body weight a day

36 Up to Date ® Database ;ADA position Statement : Nephropathy in diabetes

37 STOP !!!

38 Diabetic Nephropathy Protein Restriction ? Proteinuria :
Loss of Immunoglobulins Loss of lipoproteins Loss of tissue regeneration proteins Protein Calorie Malnutrition Protein Restriction ?

39

40 Diabetic Nephropathy …low protein diets may actually harm this population, primarily by aggravating malnutrition….

41 Diabetic Nephropathy …there is suggestive clinical and experimental evidence that dietary protein restriction may be ineffective in CKD patients receiving standard anti-proteinuric therapy with ACE inhibitors or ARB’s.

42 Diabetic Nephropathy …low protein diets are associated with both statistically and clinically significant declines in nutritional markers in CKD populations, in whom the prevalence of malnutrition is 50%.

43

44 Diabetic Nephropathy Treatment of Dyslipidemias
Important in prevention of atherosclerosis Reductase inhibitors (Statins) may protect against glomerulosclerosis ADA Goals for Lipids: LDL ≤ 100 mg/dL HDL ≥ 40 mg/dL

45 Objectives Definition of Diabetic Nephropathy
Prevention and management of Diabetic Nephropathy Nutritional Management of Diabetics with advance Renal Disease

46 Levey, A. S. et. al. Ann Intern Med 2003;139:137-147
Evidence model for stages in the initiation and progression of chronic kidney disease (CKD) and therapeutic interventions Levey, A. S. et. al. Ann Intern Med 2003;139:

47 Diabetic Nephropathy Management Early stages ( I & II) :
Strict Glycemic control !!! Potassium Restriction Treatment of dyslipidemias Sodium Restriction Remove Irritants from diet Nutritional Supplements ( FA, Iron, etc..) Family support Plan

48 Diabetic Nephropathy Management Advanced stages ( III & IV) :
Glycemic control, avoid hypoglycemia !!! Potassium Restriction !!! Phosphorus Restriction Treatment of dyslipidemias Sodium Removal from diet Remove Irritants from diet Nutritional Supplements ( FA, Iron, etc..) Prepare for Treatment

49

50 Summary Early referral is essential !!!
Work with your nephrologists or endocrinologist Identify, treat and prevent malnutrition Know your patients medications Join educational efforts

51 Thank You !!!


Download ppt "William Vega-Ocasio MD. Internal Medicine - Nephrology"

Similar presentations


Ads by Google